Physician

Nader Rahmanian, MD

According to 2025 Medicare claims, Nader Rahmanian, MD (NPI: 1124102124) practices internal medicine in the Reading, PA market, with the plurality of this provider's patient population coming from Berks, PA. This provider's primary affiliated billing organization is NADER RAHMANIAN MD LLC (NPI: 1518354851; TIN: 473229407) and primary practice location at 19610-2134. Rahmanian is affiliated with the PA Clinical Network ACO Inc (ACO ID: A5030), participating under the MSSP model.

Rahmanian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 324 traditional Medicare patients, billed 5,565 HCPCS/CPT codes, and received $271,121 in Medicare payments. The top billing code was G0439 (Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit). Part D data shows 2,533 prescription claims across 279 beneficiaries totaling $253,153 in drug costs, led by Eliquis (Apixaban). DME data shows 76 claims. Open Payments data shows 3 records totaling $58. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have fallen sharply in recent years, from $641,117 to $253,153. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $10,882 and ending at $8,987.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	432	4,722	$279,841
2016	432	4,601	$255,051
2017	417	4,501	$285,676
2018	401	4,208	$247,803
2019	368	3,822	$232,642
2020	295	2,517	$139,549
2021	354	2,620	$163,518
2022	307	3,960	$231,217
2023	329	4,625	$265,814
2024	324	5,565	$271,121

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	297	8,468	$641,117
2016	316	8,664	$649,283
2017	310	8,445	$685,727
2018	306	8,184	$654,105
2019	281	6,610	$495,943
2020	298	5,522	$402,559
2021	246	3,077	$237,719
2022	246	2,662	$228,133
2023	262	2,660	$254,911
2024	279	2,533	$253,153

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	44	244	$7,353
2016	31	137	$2,284
2017	32	195	$3,138
2018	40	313	$11,285
2019	35	358	$13,340
2020	18	260	$7,464
2021	N/R	191	$5,275
2022	N/R	117	$5,495
2023	N/R	103	$5,097
2024	N/R	76	$2,217

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	216	216	$121
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	228	435	$62
99490	Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month	207	1,046	$46
G0444	Annual depression screening, 5 to 15 minutes	207	207	$17
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	266	901	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	49	2,655	$48,971
Januvia	Sitagliptin Phosphate	31	1,470	$25,490
Ozempic	Semaglutide	25	854	$23,691
Xarelto	Rivaroxaban	24	1,200	$21,687
Creon	Lipase/Protease/Amylase	14	420	$11,371

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	15	$929
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	35	$899
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	15	$205
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	N/R	11	$185

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	3	$58	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nader Rahmanian, MD?

Tedicare shows public-source Medicare data for Nader Rahmanian, MD (NPI 1124102124), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nader Rahmanian, MD have ACO affiliation data?

Nader Rahmanian, MD is shown with ACO affiliation data for PA Clinical Network ACO Inc (MSSP, ACO ID A5030).

What billing organization is linked to Nader Rahmanian, MD?

Nader Rahmanian, MD is linked to NADER RAHMANIAN MD LLC (billing NPI 1518354851) in the available physician profile data.

Does Nader Rahmanian, MD have Open Payments data?

Nader Rahmanian, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.